Edition:
United States

Motif Bio PLC (MTFB.OQ)

MTFB.OQ on NASDAQ Stock Exchange Capital Market

8.43USD
19 Sep 2018
Change (% chg)

$0.01 (+0.12%)
Prev Close
$8.42
Open
$8.50
Day's High
$8.50
Day's Low
$8.40
Volume
319
Avg. Vol
687
52-wk High
$13.70
52-wk Low
$7.90

Chart for

About

Motif Bio plc is a clinical-stage biopharmaceutical company. The Company is engaged in development of antibiotics, which are designed for treatment of infections caused by multi-drug resistant bacteria. It operates in the development and commercialization of pharmaceutical formulations segment. The Company is focused on... (more)

Overall

Beta: 0.14
Market Cap(Mil.): £99.45
Shares Outstanding(Mil.): 296.66
Dividend: --
Yield (%): --

Financials

  MTFB.OQ Industry Sector
P/E (TTM): -- 108.51 32.45
EPS (TTM): -0.16 -- --
ROI: -598.22 1.61 12.63
ROE: -9,942.50 0.35 14.80

BRIEF-Motif Bio Says 2017 Net Loss Widened To $44.8 Mln

* REPORTED A NET LOSS OF $44.8 MILLION FOR 2017 COMPARED TO A NET LOSS OF $40.3 MILLION IN 2016

Apr 10 2018

BRIEF-Motif Bio Announces Update On NDA Submission For Iclaprim

* ‍CO HAS DECIDED THAT IN ORDER TO ENSURE A COMPLETE AND HIGH QUALITY SUBMISSION, IT WOULD BE PRUDENT TO TAKE ADDITIONAL TIME​

Mar 20 2018

Earnings vs. Estimates